ATYR
aTyr Pharma
ATYR
ATYR
23 hedge funds and large institutions have $22.9M invested in aTyr Pharma in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 25 → 23 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.55M | |
| 2 | +$485K | |
| 3 | +$349K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$162K |
| 5 |
VF
Virtu Financial
New York
|
+$108K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$411K | |
| 3 | -$346K | |
| 4 |
Two Sigma Advisers
New York
|
-$324K |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$65K |